Viatris to buy Pacira Biosciences for $1.65B
Viatris (VTRS) has agreed to buy Pacira Biosciences (PCRX) for $1.65B in cash, at $36.50 per share.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.